These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31721159)

  • 1. Pharmaceutical policies: effects of educational or regulatory policies targeting prescribers.
    Suleman F; Movik E
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31721159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical policies: effects of financial incentives for prescribers.
    Rashidian A; Omidvari AH; Vali Y; Sturm H; Oxman AD
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006731. PubMed ID: 26239041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.
    Luiza VL; Chaves LA; Silva RM; Emmerick IC; Chaves GC; Fonseca de Araújo SC; Moraes EL; Oxman AD
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD007017. PubMed ID: 25966337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical policies: effects of regulating drug insurance schemes.
    Pantoja T; Peñaloza B; Cid C; Herrera CA; Ramsay CR; Hudson J
    Cochrane Database Syst Rev; 2022 May; 5(5):CD011703. PubMed ID: 35502614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical policies: effects of financial incentives for prescribers.
    Sturm H; Austvoll-Dahlgren A; Aaserud M; Oxman AD; Ramsay C; Vernby A; Kösters JP
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006731. PubMed ID: 17636851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Aaserud M; Dahlgren AT; Kösters JP; Oxman AD; Ramsay C; Sturm H
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005979. PubMed ID: 16625648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical policies: effects of cap and co-payment on rational drug use.
    Austvoll-Dahlgren A; Aaserud M; Vist G; Ramsay C; Oxman AD; Sturm H; Kösters JP; Vernby A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD007017. PubMed ID: 18254125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public stewardship of private for-profit healthcare providers in low- and middle-income countries.
    Wiysonge CS; Abdullahi LH; Ndze VN; Hussey GD
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009855. PubMed ID: 27510030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Payment methods for healthcare providers working in outpatient healthcare settings.
    Jia L; Meng Q; Scott A; Yuan B; Zhang L
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011865. PubMed ID: 33469932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical policies: effects of policies regulating drug marketing.
    Fulone I; Cadogan C; Barberato-Filho S; Bergamaschi CC; Mazzei LG; Lopes LP; Silva MT; Lopes LC
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013780. PubMed ID: 37288951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paying for performance to improve the delivery of health interventions in low- and middle-income countries.
    Diaconu K; Falconer J; Verbel A; Fretheim A; Witter S
    Cochrane Database Syst Rev; 2021 May; 5(5):CD007899. PubMed ID: 33951190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial arrangements for health systems in low-income countries: an overview of systematic reviews.
    Wiysonge CS; Paulsen E; Lewin S; Ciapponi A; Herrera CA; Opiyo N; Pantoja T; Rada G; Oxman AD
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011084. PubMed ID: 28891235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Payment methods for outpatient care facilities.
    Yuan B; He L; Meng Q; Jia L
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011153. PubMed ID: 28253540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.
    Weeks G; George J; Maclure K; Stewart D
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011227. PubMed ID: 27873322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to improve the appropriate use of polypharmacy for older people.
    Rankin A; Cadogan CA; Patterson SM; Kerse N; Cardwell CR; Bradley MC; Ryan C; Hughes C
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD008165. PubMed ID: 30175841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Government regulation of private health insurance.
    Motaze NV; Chi PC; Ongolo-Zogo P; Ndongo JS; Wiysonge CS
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD011512. PubMed ID: 33617665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing abuse in the elderly.
    Baker PR; Francis DP; Hairi NN; Othman S; Choo WY
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010321. PubMed ID: 27528431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.